Table: begin end state 1 23 signal peptide 24 211 non-cytoplasmic 212 235 transmembrane 236 241 cytoplasmic 242 261 transmembrane 262 266 non-cytoplasmic 267 287 transmembrane 288 299 cytoplasmic 300 321 transmembrane 322 348 non-cytoplasmic 349 368 transmembrane 369 400 cytoplasmic 401 419 transmembrane 420 431 non-cytoplasmic 432 458 transmembrane 459 465 cytoplasmic 466 485 transmembrane 486 500 non-cytoplasmic
Input: >Pf6N2E2_3548 MPTALYRLILALVLLLPLEAHAGDAEDFVAANPTQQAKLLETWAAQPEPERVELINALQQ GQLTVDGQPKTLRLNNRLRGLIETALASHQLLAVDARVRLGAAQQLQKTARPAQLAFLDR QLAGEQDEDVHAALSLALANLQLVDTNPNVRLAAVRLLGETGDPLARTRLEGLLEPGVET DANVRTAAETSLAQVKRKLLVGELLGQAFSGMSLGSILLLAALGLAITFGLLGVINMAHG EMLMLGAYSTYVVQMLFQRFAPNAIEFYPLIALPVAFFITAAIGMALERTVIRHLYGRPL ETLLATWGISLMLIQLVRLVFGAQNVEVANPAWLSGGIQVLPNLVLPYNRIVIIAFALFV VVLTWLLLNKTRLGLNVRAVTQNRNMAACCGVPTGRVDMLAFGLGSGIAGLGGVALSQIG NVGPDLGQSYIIDSFLVVVLGGVGQLAGSVFAAFGLGIANKILEPQIGAVLGKILILALI ILFIQKRPQGLFALKGRVID
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server